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ABSTRACT; 
Background; Melasma has a significant impact on appearance, causing psychosocial and emotional distress, and 
reducing the quality of life of the affected patients. In this context, it has a negative impact on the quality of life 
of patients, affecting their psychological and emotional well-being, which often motivates them to search for a 
dermatologist. Objective; To compare mean MASI score of in patients with epidermal melasma treated with 30 
% salicylic acid versus Jessner solution chemical peeling. Material and methods; A total of 396 patients were 
taken in our study. Patients was randomly allocated in to two groups by lottery method. Group A, having 198 
patients, were treated with 30 % salicylic acid while group B, having 198 patients, with Jessner solution 
chemical peeling in patients. After two weeks of priming, which was comprised of nightly application of 0.05% 
tretinoin and daytime sunscreen with a sun protection factor of 60, treatment according to the group was started. 
Night-time use of moisturizer was applied in all patients and asked for follow up visits after 2 weeks till 12 
weeks to document final outcome. Baseline and post-treatment MASI scores was calculated and patients were 
followed weekly till 12 weeks from the beginning of therapy to document efficacy. Results; Of these 396 study 
cases, 126 (31.8 %) were male patients while 270 (68.2 %) were female patients. Mean age of our study cases 
was 27.20 ± 5.08 years.  Mean body mass index of our study cases was 24.82 ± 2.51 kg/m
2 
and obesity was 
present in 28 (7.1 %) of our study cases. Fitzpatrick Skin type III was noted in 270 (68.2%) and skin type III was 
noted in 126 (31.8%) of our study cases. Mean disease duration was 10.62 ± 5.92 months and 293 (74 %) had 
duration of illness up to 1 year. Mean post treatment MASI score in our study was noted to 9.31 ±2.93 while 
mean MASI in group A was 7.59 ± 3.02 while in group B mean MASI was 11.03 ± 1.48 (p = 0.000). 
Conclusion; Our study results have indicated that 30 % salicylic acid is more effective in treatment of epidermal 
melasma as compared with Jessner solution as there was significant reduction of mean MASI score in our 
patients and it provides rapid and sustained clinical improvement in the treatment of melasma. The results of this 
study support use of 30 % salicylic acid among targeted population which had significant impact on the 
improvement of quality of life of these patients and relieved them from psychological stress of this disease. 
Proper management of melasma helps improve productivity of the patients as it hits main working force of the 
society, hence plays important role in the national productivity and health economy. 
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INTRODUCTION; 
Melasma is an acquired pigment disorder showing symmetrical hyperpigmentation of the face 
characterized by light to dark brown patches with indistinct borders on both cheeks. Melasma is prevalent in 
middle-aged women with harmless hormone imbalances. It is also known as the mask of pregnancy and is 
prevalent in most child-bearing women 
1-3
. Three clinical presentations of melasma were identified based on 
histopathologic findings: epidermal melasma, when the pigment is deposited in the basal and suprabasal layer; 
dermal melasma, when melanophages filled with melanin are found in the superficial and middle dermis; mixed 
melasma, when findings of the two previous types of melasma are present. The examination in Wood's light 
contributes to differentiate the epidermal from dermal melasma in types I-IV of Fitzpatrick scale. Considering its 
recalcitrant characteristics, treatment can rarely keep the individual free of melasma for a long time, despite the 
many proposals available.4,5 Melasma is reported to account for 4%–10% of new dermatology hospital referrals. 
It is shown to be more common in people of Hispanic origin and among Asians. Treatment of melasma is 
unsatisfactory most of the times, even by tolerating various side effects such as contact dermatitis, irritation, and 
scarring.
6, 7
 According to the most recent Cochrane review, evidence shows insufficiency to provide robust 
guidance for practice, and more randomized clinical trials are needed in the field of melasma treatment.8 The 
range of treatments investigated for melasma covers all systemic, procedural, and topical modalities. Topical 
treatments have their own advantage over systemic therapies being among the most common interventions 
investigated and used for treating melasma.
9 
Superficial chemical peeling as a treatment modality in epidermal 
melasma is a new weapon in the therapeutic armamentarium. Salicylic acid is among the commonest and most 
successful superficial chemical peeling agents used in epidermal melasma. It has keratolytic, comedolytic and 
anti-inflammatory properties. It solubilizes intercellular cement, reduces corneocytes adhesion, and sloughs off 
the superficial layers of skin. Although, the literature is replete with the use of alpha hydroxyl acids as peeling 
agents, there is a dearth of published data regarding the efficacy and safety of salicylic acid peels in Asian skin 
10
. 
Jessner's peel is a combination of salicylic acid 14%, lactic acid 14%, and resorcinol 14% in alcohol. Jessner’s 
solution has been use for over 100 years and thus has an extremely long history of safety and efficacy. 
Traditionally, it has been used as a penetration enhancing agent, by sloughing off the keratin layer, in 
combination with 35% trichloroacetic acid for medium depth chemical peeling. Recently, it has been shown to 
be an effective superficial chemical peeling agent when used alone 
11
.  
Ejaz et al from Kharian 
 12 
has reported mean pretreatment MASI score was 6.5 ± 3.84 which reduced to 2.9 ± 
3.03 in patients treated with Jessner’s solution while in patients treated with 30 % salicylic acid it was 5.9 ± 3.11 
which dropped to 2.1 ± 2.63 after 12 weeks of therapy.  
Melasma is associated with certain psychological and social implications for the sufferers and there is a 
scarcity of data  comparing effectiveness of these treatments.  
 
MATERIAL AND METHODS; 
Patients meeting inclusion criteria criteria was enrolled in this study from OPD of Department of Dermatology, 
Nishtar Hospital Multan. Patients with age ≥ 20 and ≤ 40 years having epidermal melasma on Wood’s lamp 
examination (spots are light brown with well-defined margins and hyperpigmentation is clearly visible) with 
baseline MASI score > 12 of either sex were enrolled in our study. Fitzpatrick skin type III, IV and V were taken 
only. Dermal and mixed melasma, Fitzpatrick skin type I, II and VI, already taking treatment for melasma within 
3 months, history of hypertrophic scars, hirsutism and menstrual dysfunction, pregnant ladies, known cases with 
diabetes and hypertension, and females taking oral contraceptives.  
Melasma  Assessment Severity Index (MASI): Melasma area severity index (MASI) is the severity of the 
melasma in each of the four regions (forehead, right malar region, left malar region and chin) is assessed based 
on three variables: percentage of the total area involved (A), darkness (D), and homogeneity (H),attached as 
annexure “II” to this synopsis.  
A total of 396 patients were taken in our study. Patients was randomly allocated in to two groups by lottery 
method. Group A, having 198 patients, were treated with 30 % salicylic acid while group B, having 198 patients, 
with Jessner solution chemical peeling in patients. After two weeks of priming, which was comprised of nightly 
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application of 0.05% tretinoin and daytime sunscreen with a sun protection factor of 60, treatment according to 
the group was started. Night-time use of moisturizer was applied in all patients and asked for follow up visits 
after 2 weeks till 12 weeks to document final outcome. Baseline and post-treatment MASI scores was calculated 
and patients were followed weekly till 12 weeks from the beginning of therapy to document efficacy. All the 
data was entered and analyzed using SPSS-18. Mean and standard deviation for the age, BMI of patient and 
duration of disease was calculated. Frequencies and percentage were calculated for the categorical variables like 
gender, Fitzpatrick skin type, age groups and Obesity (Obese/Non-obese).  Paired sample t – test was applied for 
comparison of post – treatment MASI score.  
RESULTS; 
Our study comprised of a total of 396 patients meeting inclusion criteria of our study. Of these 396 study cases, 
126 (31.8 %) were male patients while 270 (68.2 %) were female patients. Mean age of our study cases was 
27.20 ± 5.08 years (with minimum age of our study cases was 20 years while maximum age was 40 years). Mean 
age of the male patients was noted to be 28.02 ± 4.25 years while that female patients was 26.81 ± 5.39 years 
(p=0.028). Our study results have indicated that majority of our study cases i.e. 286 (72.2 %) were aged up to 30 
years. Of these 396 study cases, 155 (39.1 %) belonged to rural areas and 241 (60.9%) belonged to urban areas. 
Of these 396 study cases, 155 (39.1%) were illiterate while 241 (60.9%) were literate.  Mean body mass index of 
our study cases was 24.82 ± 2.51 kg/m
2 
and obesity was present in 28 (7.1 %) of our study cases. Fitzpatrick 
Skin type III was noted in 270 (68.2%) and skin type III was noted in 126 (31.8%) of our study cases. Mean 
disease duration was 10.62 ± 5.92 months and 293 (74 %) had duration of illness up to 1 year. Mean post 
treatment MASI score in our study was noted to 9.31 ±2.93 while mean MASI in group A was 7.59 ± 3.02 while 
in group B mean MASI was 11.03 ± 1.48 (p = 0.000).  
 
 
Table No. 1 
Distribution of post treatment MASI score among study cases in both groups. 
(n = 396) 
Groups 
Post Treatment MASI 
P value 
Mean SD 
 
Group A 
 
 
7.59 
 
 
3.02 
 
0.000 
 
Group B 
 
 
11.03 
 
 
1.48 
 
 
 
DISCUSSION; 
Melasma is a human melanogenesis dysfunction that results in localized, chronic acquired hypermelanosis of the 
skin. It occurs symmetrically on sunexposed areas of the body, and affects especially women in menacme 
13-15
.
 
Patients commonly report feelings of shame, low self-esteem, anhedonia, dissatisfaction, and the lack of 
motivation to go out. Suicidal ideas have also been reported in the literature. There is also a clear genetic 
predisposition, since over 40% of patients reported having relatives affected with the disease 
16
. 
Our study comprised of a total of 396 patients meeting inclusion criteria of our study. Of these 396 study cases, 
126 (31.8 %) were male patients while 270 (68.2 %) were female patients. Similar results have been reported in 
many different studies indicating high female gender preponderance over male patients. A study conducted by 
Ejaz et al 
12 
from Kharian has also reported high female gender predominance with 85 % female patients which 
is in compliance with our study results. An Indian study conducted by Puri et al 
17 
has reported 6.5 : 1 female 
gender predominance which is in compliance with our study results.  
Mean age of our study cases was 27.20 ± 5.08 years (with minimum age of our study cases was 20 years while 
maximum age was 40 years). Mean age of the male patients was noted to be 28.02 ± 4.25 years while that female 
patients was 26.81 ± 5.39 years (p=0.028). Our study results have indicated that majority of our study cases i.e. 
286 (72.2 %) were aged up to 30 years. A study conducted by Ejaz et al 
 12 
from Kharian has reported 30.4 ± 5.8 
years mean age of the patients with epidermal melasma which is in compliance with our study results. Ali et al 18 
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from Lahore reported similar mean of patients in which majority of them were young with melasma i.e. 29.90 ± 
7.18 years. Their findings are close to our study findings. Similar results have been reported by Halder et al
19
.  
Of these 396 study cases, 155 (39.1 %) belonged to rural areas and 241 (60.9%) belonged to urban areas. Of 
these 396 study cases, 155 (39.1%) were illiterate while 241 (60.9%) were literate.  Mean body mass index of 
our study cases was 24.82 ± 2.51 kg/m
2 
and obesity was present in 28 (7.1 %) of our study cases. Fitzpatrick 
Skin type III was noted in 270 (68.2%) and skin type III was noted in 126 (31.8%) of our study cases.  A study 
conducted by Ejaz et al  12 reported similar results.  
Mean disease duration was 10.62 ± 5.92 months and 293 (74 %) had duration of illness up to 1 year. Mean post 
treatment MASI score in our study was noted to 9.31 ±2.93 while mean MASI in group A was 7.59 ± 3.02 while 
in group B mean MASI was 11.03 ± 1.48 (p = 0.000). Ejaz et al from Kharian 
 12 
has reported mean pretreatment 
MASI score was 6.5 ± 3.84 which reduced to 2.9 ± 3.03 in patients treated with Jessner’s solution while in 
patients treated with 30 % salicylic acid it was 5.9 ± 3.11 which dropped to 2.1 ± 2.63 after 12 weeks of therapy. 
These findings are in compliance with our study results.  
 
CONCLUSION; 
Our study results have indicated that 30 % salicylic acid is more effective in treatment of epidermal melasma as 
compared with Jessner solution as there was significant reduction of mean MASI score in our patients and it 
provides rapid and sustained clinical improvement in the treatment of melasma. The results of this study support 
use of 30 % salicylic acid among targeted population which had significant impact on the improvement of 
quality of life of these patients and relieved them from psychological stress of this disease. Proper management 
of melasma helps improve productivity of the patients as it hits main working force of the society, hence plays 
important role in the national productivity and health economy.  
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